"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
(Generic versions may still be available.)
Gantanol® (sulfamethoxazole) is an intermediate-dosage antibacterial sulfonamide available in tablets. Each tablet contains 0.5 g sulfamethoxazole plus cornstarch, polyvinyl acetate, polyvinyl alcohol, magnesium stearate, FD&C Blue No. 1 Lake, FD&C Yellow No. 6 Lake and D&C Yellow No. 10 Lake.
Sulfamethoxazole is N1-(5-methyl-3-isoxazolyl)sulfanilamide. It is an almost white, odorless, tasteless compound with a molecular weight of 253.28.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Gantanol Information
- Gantanol Drug Interactions Center: sulfamethoxazole oral
- Gantanol Side Effects Center
- Gantanol FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.